Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Wigren

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Circulation|May 29, 2019
Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE<sup>-/-</sup> MiceMaria Wigren, Sara Rattik, Ingrid Yao Mattisson, et al.
Vascular Pharmacology|April 15, 2021
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosusIngrid Yao Mattisson, Sara Rattik, Harry Björkbacka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2014
High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary eventsSara Rattik, Maria Wigren, Harry Björkbacka, et al.
Atherosclerosis|February 7, 2018
Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosisMaria Wigren, Elisabet Svenungsson, Ingrid Yao Mattisson, et al.
Ebiomedicine|December 7, 2017
Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular DiseaseIngrid Yao Mattisson, Harry Björkbacka, Maria Wigren, et al.
Vascular Pharmacology|September 24, 2018
B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient miceSara Rattik, Polyxeni T Mantani, Ingrid Yao Mattisson, et al.
Plos One|June 12, 2013
Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic miceAnna V Zetterqvist, Lisa M Berglund, Fabiana Blanco, et al.
Journal of Diabetes Research|April 29, 2015
Nuclear factor of activated T cells is activated in the endothelium of retinal microvessels in diabetic miceAnna V Zetterqvist, Fabiana Blanco, Jenny Öhman, et al.
BMC Cardiovascular Disorders|September 7, 2016
Association between renin and atherosclerotic burden in subjects with and without type 2 diabetesIsabel Gonçalves, Andreas Edsfeldt, Helen M Colhoun, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Circulation|May 29, 2019
Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE<sup>-/-</sup> MiceMaria Wigren, Sara Rattik, Ingrid Yao Mattisson, et al.
Vascular Pharmacology|April 15, 2021
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosusIngrid Yao Mattisson, Sara Rattik, Harry Björkbacka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2014
High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary eventsSara Rattik, Maria Wigren, Harry Björkbacka, et al.
Atherosclerosis|February 7, 2018
Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosisMaria Wigren, Elisabet Svenungsson, Ingrid Yao Mattisson, et al.
Ebiomedicine|December 7, 2017
Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular DiseaseIngrid Yao Mattisson, Harry Björkbacka, Maria Wigren, et al.
Vascular Pharmacology|September 24, 2018
B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient miceSara Rattik, Polyxeni T Mantani, Ingrid Yao Mattisson, et al.
Plos One|June 12, 2013
Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic miceAnna V Zetterqvist, Lisa M Berglund, Fabiana Blanco, et al.
Journal of Diabetes Research|April 29, 2015
Nuclear factor of activated T cells is activated in the endothelium of retinal microvessels in diabetic miceAnna V Zetterqvist, Fabiana Blanco, Jenny Öhman, et al.
BMC Cardiovascular Disorders|September 7, 2016
Association between renin and atherosclerotic burden in subjects with and without type 2 diabetesIsabel Gonçalves, Andreas Edsfeldt, Helen M Colhoun, et al.
Pageof 3